Liabilities and Equity of Neuphoria Therapeutics Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Neuphoria Therapeutics Inc. quarterly Liabilities and Equity in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
Neuphoria Therapeutics Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $27,343,913, a 19% increase year-over-year.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$27,343,913	+$4,426,706	+19%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q1
Q2 2025	$28,589,614	+$940,521	+3.4%	30 Jun 2025	10-Q	14 Nov 2025	2025	Q1
Q1 2025	$30,713,319			31 Mar 2025	10-Q	20 May 2025	2025	Q3
Q4 2024	$18,168,220			31 Dec 2024	10-Q	14 Feb 2025	2025	Q2
Q3 2024	$22,917,207			30 Sep 2024	10-Q	14 Nov 2024	2025	Q1
Q2 2024	$27,649,093	-$913,855	-3.2%	30 Jun 2024	10-K	29 Sep 2025	2025	FY
Q2 2023	$28,562,948			30 Jun 2023	10-K	30 Sep 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.